CCM
RETA

Camber Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Camber Capital Management’s Portfolio RETA Stock Details RETA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
2022
Q3 		$12.6M Sell
2022
Q2 		$45.6M Hold
2022
Q1 		$49.1M Buy
2021
Q4 		– Sell
2021
Q3 		$68.9M Buy
2021
Q2 		$65.8M Buy
2021
Q1 		$39.9M Buy